Evaluating the Effectiveness of Typology-based Coaching on Patients' Therapy Management

NCT07708571 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 548

Last updated 2026-07-16

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the effect of patient education and patient typology-based coaching on therapy persistence in breast cancer patients taking ribociclib. Researchers will compare the time to permanent treatment discontinuation of patients receiving personalized coaching to the time to permanent treatment discontinuation of patients who only receive standard of care education and counselling, to see if adherence to treatment can be improved by personalized patient coaching.

Conditions

  • HR+/HER2- Early Breast Cancer

Interventions

BEHAVIORAL

Typology-based coaching

Standardized patient coaching based on the Multinational Association of Supportive Care in Cancer (MASCC) Oral Agent Teaching Tool© (MOATT)

Sponsors & Collaborators

  • Institut fuer Frauengesundheit

    lead OTHER

Principal Investigators

  • Manfred Welslau, Dr. med. · MVZ Klinikum Aschaffenburg, Zweigstelle Hänatologie und Onkologie

  • Nina Ditsch, Prof. Dr. med. · Department of Gynecology and Obstetrics, Universitätsklinikum Augsburg

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-04
Primary Completion
2030-06-30
Completion
2030-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07708571 on ClinicalTrials.gov